Cost-effectiveness modelling of low-dose aspirin for the primary prevention of cardiovascular disease.

被引：0
|
作者：
Liew, D [1 ]
Vos, T [1 ]
Bertram, M [1 ]
Lim, S [1 ]
McNeil, JJ [1 ]
机构：
[1] Monash Univ, Melbourne, Vic 3004, Australia
来源：
CIRCULATION | 2004年 / 109卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P49
引用
收藏
页码：E90 / E90
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of proton pump inhibitor cotherapy in patients taking long-term, low-dose aspirin for secondary cardiovascular prevention
    Saini, Sameer D.
    Schoenfeld, Philip
    Fendrick, A. Mark
    Scheiman, James
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (15) : 1684 - 1690
  • [32] Pravastatin cost-effectiveness for primary prevention of cardiovascular disease in the US
    Hay, JW
    Yuan, Y
    Ford, I
    McGuire, A
    Shepherd, J
    CIRCULATION, 1997, 96 (08) : 1017 - 1017
  • [33] LOW-DOSE WARFARIN AND LOW-DOSE ASPIRIN IN THE PRIMARY PREVENTION OF ISCHEMIC-HEART-DISEASE
    MEADE, TW
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (06): : C7 - C11
  • [34] Low-Dose Aspirin for Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease
    Kim, Ae Jin
    Lim, Hye Jin
    Ro, Han
    Ko, Kwang-Pil
    Han, Song Yi
    Chang, Jae Hyun
    Lee, Hyun Hee
    Chung, Wookyung
    Jung, Ji Yong
    PLOS ONE, 2014, 9 (08):
  • [35] Low-dose aspirin in primary prevention revisited
    Pines, Amos
    CLIMACTERIC, 2014, 17 (03) : 310 - 311
  • [36] Aspirin overuse in primary prevention: nationwide temporal trends in low-dose aspirin therapy for primary prevention of cardiovascular disease in adults with and without diabetes
    Kristensen, A. M. D.
    Pareek, M.
    Kragholm, K.
    Torp-Pedersen, C.
    Mcevoy, J. W.
    Prescott, E.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [37] Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study
    Linda J Cobiac
    Anne Magnus
    Jan J Barendregt
    Rob Carter
    Theo Vos
    BMC Public Health, 12
  • [38] Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study
    Cobiac, Linda J.
    Magnus, Anne
    Barendregt, Jan J.
    Carter, Rob
    Vos, Theo
    BMC PUBLIC HEALTH, 2012, 12
  • [39] Cost-effectiveness of a randomized controlled trial comparing low-dose aspirin to placebo for the prevention of recurrent preterm birth
    Landman, Anadeijda J. E. M. C.
    Broulikova, Hana M.
    Visser, Laura
    Nijman, Tobias A. J.
    Hemels, Marieke A. C.
    Vollebregt, Karin C.
    Boormans, Elisabeth M. A.
    Bremer, Henk A.
    Tuinman, Esther
    Langenveld, Josje
    van Der Made, Flip
    Rijnders, Robbert J. P.
    van Vliet, Huib A. A. M.
    Freeman, Liv M.
    de Heus, Roel
    Blaauw, Judith
    Krabbendam, Ineke
    van de Laar, Rafli
    Verberg, Marieke F. G.
    Scheepers, Hubertina C. J.
    Mol, Ben W.
    de Groot, Christianne J. M.
    Oudijk, Martijn A.
    Bosmans, Judith E.
    de Boer, Marjon A.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2025, 169 (01) : 399 - 407
  • [40] Low-dose aspirin for primary cardiovascular prevention in diabetic patients: the issue to believe it or not
    Lamendola, Priscilla
    Villano, Angelo
    Fusco, Augusto
    Leggio, Massimo
    ANNALS OF TRANSLATIONAL MEDICINE, 2018, 6 (11)
12345